Free Trial

Jasper Therapeutics (JSPR) Insider Trading & Ownership

Jasper Therapeutics logo
$0.93 +0.02 (+1.97%)
Closing price 04:00 PM Eastern
Extended Trading
$0.93 +0.00 (+0.40%)
As of 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Jasper Therapeutics (NASDAQ:JSPR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.60%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$347.49K
Number Of
Insiders Selling
(Last 12 Months)
0
Get JSPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

JSPR Insider Buying and Selling by Quarter

Jasper Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/22/2025
Judith Anne Shizuru
Director
Buy41,000$2.43$99,630.00  
9/22/2025
Ron Martell
CEO
Buy41,000$2.43$99,630.00  
9/22/2025
Svetlana Lucas
Director
Buy20,000$2.43$48,600.00  
9/22/2025
Thomas G Wiggans
Director
Buy41,000$2.43$99,630.00  
(Data available from 1/1/2013 forward)

JSPR Insider Trading Activity - Frequently Asked Questions

The list of insiders at Jasper Therapeutics includes Jeetinder Singh Mahal, Judith Anne Shizuru, Ron Martell, Svetlana Lucas, Thomas G Wiggans, Velan Capital Investment Manag, and William Lis. Learn more on insiders at JSPR.

4.60% of Jasper Therapeutics stock is owned by insiders. Learn more on JSPR's insider holdings.

The following insiders have purchased JSPR shares in the last 24 months: Judith Anne Shizuru ($99,630.00), Ron Martell ($99,630.00), Svetlana Lucas ($48,600.00), and Thomas G Wiggans ($99,630.00).

Insiders have purchased a total of 143,000 JSPR shares in the last 24 months for a total of $347,490.00 bought.

The following insider sold JSPR shares in the last 24 months: Jeetinder Singh Mahal ($60,750.00).

Insiders have sold a total of 2,700 Jasper Therapeutics shares in the last 24 months for a total of $60,750.00 sold.



This page (NASDAQ:JSPR) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners